Log In
BCIQ
Print this Print this
 

IONIS-ANGPTL3-LRx

  Manage Alerts
Collapse Summary General Information
Company Ionis Pharmaceuticals Inc.
DescriptionLigand conjugated antisense version of an oligonucleotide that inhibits apolipoprotein A
Molecular Target
Mechanism of ActionGene silencing
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPhase II
Standard IndicationHyperlipidemia
Indication DetailsTreat hyperlipidemia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today